Infinity Pharmaceuticals Inc (OTCPK:INFIQ)
$ 0.0001 0 (0%) Market Cap: 9,000.00 Enterprise Value: -17.10 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2019 Infinity Pharmaceuticals Inc Earnings Call Transcript

Mar 03, 2020 / 09:30PM GMT
Release Date Price: $1.1 (-6.78%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals' Corporate Update and Full Year 2019 Financial Results Conference Call. My name is Daniel, and I'll be your operator for today's call. (Operator Instructions) Please be advised that this call is being recorded at Infinity's request.

Now I would like to introduce your host for today's call, Jayne Kauffman, Senior Executive Coordinator at Infinity Pharmaceuticals. Please go ahead.

Jayne Kauffman
Infinity Pharmaceuticals, Inc. - Senior Executive Coordinator

Thank you, Daniel, and good afternoon, everyone. Welcome to today's call. We are pleased to discuss our recent significant business progress, review our full year 2019 financial results and provide our key milestones for 2020.

With me here today are Adelene Perkins, Chief Executive Officer; Larry Bloch, President; and Dr. Jeff Kutok, our Chief Scientific Officer. We will open up the call for Q&A following our remarks. The press release issued this afternoon details our results and are available at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot